Apnea Sciences Coporation

Apnea Sciences Corporation specializes in diagnostic devices. Specifically, they produce the ApneaRX Pro, which is designed to monitor and analyze sleep apnea and associated respiratory events in patients. This device helps healthcare providers assess conditions like obstructive sleep apnea by tracking breathing patterns and oxygen levels during sleep.

Apnea Sciences Corporation is headquartered in the United States. The company’s location ensures compliance with U.S. regulatory standards, which govern the development, testing, and distribution of its medical devices.

The ApneaRX Pro, the primary device manufactured by Apnea Sciences Corporation, is classified as a Class II medical device by the FDA. This classification is based on its intended use—diagnosing sleep-related breathing disorders—and the associated risk level, which requires special controls to ensure safety and effectiveness without needing the stringent premarket approval process of Class III devices.

Yes, the ApneaRX Pro is listed in the FDA’s 510(k) clearance registry. This registry documents devices that have been determined to be substantially equivalent to a legally marketed predicate device, allowing them to enter the market through the 510(k) clearance pathway. Listing in this registry provides transparency about the device’s regulatory status and compliance with FDA requirements.